tradingkey.logo
tradingkey.logo
Search

Nautilus Biotechnology Inc

NAUT
Add to Watchlist
1.810USD
+0.040+2.26%
Close 07-23 16:00ETQuotes delayed by 15 min
228.91MMarket Cap
LossP/E TTM

NAUT Financials

See Nautilus Biotechnology Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Nautilus Biotechnology Inc Earnings Date

Latest Release
Jul 28, 2026
EPS / Forecast
--/-0.14
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.47
17.19%
Analyst Rating
STRONG BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
11.88%-0.12
22.03%-0.11
18.02%-0.11
17.11%-0.12
12.20%-0.13
-2.68%-0.14
-3.15%-0.13
-13.27%-0.14
-24.89%-0.15
-26.77%-0.14
---0.13
---0.13
---0.12
---0.11
---0.36
----
----
----
----
----
Net Profit
11.53%-14.70M
21.67%-13.78M
17.46%-13.57M
16.53%-15.03M
11.30%-16.61M
-3.35%-17.59M
-3.58%-16.45M
-13.93%-18.01M
-25.16%-18.73M
-26.96%-17.02M
-12.91%-15.88M
-7.62%-15.81M
5.06%-14.96M
19.65%-13.41M
3.04%-14.06M
-37.11%-14.69M
-87.45%-15.76M
---16.69M
-264.61%-14.50M
-219.31%-10.71M
Operating profit
14.43%-16.12M
22.80%-15.42M
18.99%-15.47M
17.76%-17.10M
12.79%-18.84M
0.10%-19.98M
-0.13%-19.10M
-9.32%-20.79M
-19.64%-21.61M
-22.68%-20.00M
-20.58%-19.07M
-22.91%-19.02M
-12.72%-18.06M
3.04%-16.30M
-8.59%-15.82M
-44.64%-15.47M
-90.35%-16.02M
---16.82M
-261.76%-14.57M
-214.62%-10.70M
Net Profit
11.53%-14.70M
21.67%-13.78M
17.46%-13.57M
16.53%-15.03M
11.30%-16.61M
-3.35%-17.59M
-3.58%-16.45M
-13.93%-18.01M
-25.16%-18.73M
-26.96%-17.02M
-12.91%-15.88M
-7.62%-15.81M
5.06%-14.96M
19.65%-13.41M
3.04%-14.06M
-37.11%-14.69M
-87.45%-15.76M
---16.69M
-264.61%-14.50M
-219.31%-10.71M
Current assets
-30.20%98.83M
-20.22%105.96M
-6.85%134.32M
-11.82%150.72M
-23.50%141.60M
-24.89%132.83M
-22.80%144.21M
2.54%170.93M
8.57%185.09M
-5.54%176.84M
-28.50%186.79M
-45.06%166.70M
-47.87%170.48M
-46.39%187.21M
-25.84%261.22M
-19.00%303.45M
370.97%327.06M
--349.22M
--352.22M
--374.63M
Total current liabilities
2.29%8.34M
4.19%7.95M
3.69%8.98M
-6.27%8.14M
-11.46%8.16M
-16.33%7.63M
-2.61%8.66M
10.03%8.68M
16.18%9.21M
34.32%9.12M
38.23%8.89M
29.37%7.89M
23.77%7.93M
16.84%6.79M
52.86%6.43M
88.77%6.10M
41.57%6.41M
--5.81M
--4.21M
--3.23M
Total assets
-21.92%177.78M
-21.27%191.11M
-22.64%200.91M
-21.84%213.19M
-21.12%227.69M
-20.56%242.74M
-18.42%259.70M
-17.54%272.75M
-16.55%288.65M
-12.71%305.56M
-11.40%318.34M
-11.01%330.77M
-10.08%345.88M
-12.15%350.05M
-6.76%359.31M
-5.48%371.71M
405.16%384.67M
--398.45M
--385.35M
--393.27M
Total liabilities
0.33%33.36M
0.37%34.14M
-12.39%31.78M
-14.34%32.09M
-15.07%33.26M
-15.42%34.01M
-11.67%36.27M
-8.82%37.47M
-7.14%39.16M
14.47%40.21M
20.88%41.06M
20.34%41.09M
20.61%42.17M
0.73%35.13M
352.92%33.97M
956.92%34.15M
672.69%34.96M
--34.87M
--7.50M
--3.23M
Total equity
-25.73%144.41M
-24.80%156.97M
-24.30%169.14M
-23.03%181.09M
-22.07%194.44M
-21.34%208.73M
-19.42%223.43M
-18.78%235.28M
-17.85%249.49M
-15.74%265.35M
-14.77%277.27M
-14.19%289.67M
-13.15%303.71M
-13.38%314.92M
-13.90%325.34M
-13.46%337.56M
388.26%349.71M
--363.58M
--377.85M
--390.04M
Net operating income
6.01%-13.10M
13.52%-12.38M
15.85%-11.03M
13.63%-13.35M
14.32%-13.94M
-2.94%-14.31M
-11.71%-13.11M
-14.08%-15.46M
-29.88%-16.27M
-33.95%-13.90M
-22.72%-11.74M
-0.15%-13.55M
-1.53%-12.52M
1.35%-10.38M
32.53%-9.56M
-63.16%-13.53M
-97.27%-12.34M
---10.52M
-320.56%-14.18M
-153.04%-8.29M
Net investment
-27.05%14.23M
-97.88%787.00K
106.02%452.00K
1.26%14.47M
-12.71%19.51M
190.37%37.11M
-157.38%-7.50M
733.88%14.29M
265.64%22.35M
35.90%-41.06M
209.48%13.07M
-106.43%-2.25M
-188.89%-13.49M
-1156.32%-64.06M
85.78%-11.94M
141.48%35.08M
-35.45%15.18M
--6.06M
-415.59%-83.98M
-85.56%-84.57M
Net financing
6038.89%1.10M
-77.05%101.00K
-100.00%0.00
-70.22%95.00K
-92.65%18.00K
73.91%440.00K
775.00%140.00K
225.51%319.00K
24400.00%245.00K
87.41%253.00K
-81.40%16.00K
-47.03%98.00K
-99.36%1.00K
114.29%135.00K
681.82%86.00K
-99.94%185.00K
107.54%156.00K
--63.00K
-60.71%11.00K
334.27%329.44M

FAQs

What are the current assets of Nautilus Biotechnology Inc?

According to Nautilus Biotechnology Inc's FY2025 earnings report, its current assets were 105.96M, with a year-on-year change of -20.22.

What are the total assets of Nautilus Biotechnology Inc?

According to Nautilus Biotechnology Inc's FY2025 earnings report, its total assets of Nautilus Biotechnology Inc were 191.11M, with a year-on-year change of -21.27.

What are the total liabilities of Nautilus Biotechnology Inc?

According to Nautilus Biotechnology Inc's FY2025 earnings report, its total liabilities of Nautilus Biotechnology Inc were 34.14M, with a year-on-year change of 0.37.

What is the total equity of Nautilus Biotechnology Inc?

According to Nautilus Biotechnology Inc's FY2025 earnings report, its total equity of Nautilus Biotechnology Inc was 156.97M, with a year-on-year change of -24.80.

What is the net operating income of Nautilus Biotechnology Inc?

According to Nautilus Biotechnology Inc's FY2025 earnings report, its net operating income of Nautilus Biotechnology Inc was -66.84M, with a year-on-year change of 17.97.

What is the net investment of Nautilus Biotechnology Inc?

According to Nautilus Biotechnology Inc's FY2025 earnings report, its net investment of Nautilus Biotechnology Inc was 35.22M, with a year-on-year change of -46.83.

What is the net financing of Nautilus Biotechnology Inc?

According to Nautilus Biotechnology Inc's FY2025 earnings report, its net financing of Nautilus Biotechnology Inc was 214.00K, with a year-on-year change of -81.29.

What is the Earnings Per Share (EPS) of Nautilus Biotechnology Inc?

According to Nautilus Biotechnology Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.47, with a year-on-year change of 17.19.

What is the net income of Nautilus Biotechnology Inc?

According to Nautilus Biotechnology Inc's FY2025 earnings report, its net income was -59.00M, with a year-on-year change of 16.64.

What is the Return on Equity (ROE) of Nautilus Biotechnology Inc?

According to Nautilus Biotechnology Inc's FY2025 earnings report, its Return on Equity (ROE) was -32.27, with a year-on-year change of -8.06.

What is the Return on Assets (ROA) of Nautilus Biotechnology Inc?

According to Nautilus Biotechnology Inc's FY2025 earnings report, its Return on Assets (ROA) was -27.20, with a year-on-year change of -5.35.

What is the operating profit of Nautilus Biotechnology Inc?

According to Nautilus Biotechnology Inc's FY2025 earnings report, its operating profit was -66.84M, with a year-on-year change of 17.97.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.